| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.44B | 23.97B | 23.26B | 21.23B | 19.28B | 23.93B |
| Gross Profit | 9.19B | 9.11B | 8.78B | 8.03B | 7.63B | 7.29B |
| EBITDA | 1.70B | 1.83B | 1.92B | 1.51B | 1.32B | 1.18B |
| Net Income | 740.00M | 748.00M | 768.00M | 602.00M | 178.00M | 304.00M |
Balance Sheet | ||||||
| Total Assets | 20.52B | 19.66B | 18.93B | 16.58B | 15.11B | 14.60B |
| Cash, Cash Equivalents and Short-Term Investments | 2.26B | 1.77B | 1.57B | 1.08B | 904.00M | 965.55M |
| Total Debt | 7.57B | 7.29B | 6.75B | 6.56B | 5.43B | 4.74B |
| Total Liabilities | 13.30B | 12.43B | 12.29B | 10.95B | 10.00B | 9.26B |
| Stockholders Equity | 7.22B | 7.22B | 6.63B | 5.62B | 5.10B | 5.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -76.00M | 1.13B | -401.00M | 276.00M | 1.13B |
| Operating Cash Flow | 0.00 | 838.00M | 1.69B | 1.14B | 922.00M | 1.34B |
| Investing Cash Flow | 0.00 | -828.00M | -988.00M | -1.68B | -481.00M | -143.00M |
| Financing Cash Flow | 0.00 | 192.00M | -206.00M | 748.00M | -509.00M | -1.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.53B | 12.33 | ― | 1.43% | 10.77% | 131.68% | |
74 Outperform | ¥12.35B | 11.50 | ― | 2.61% | 2.42% | 33.84% | |
70 Outperform | ¥17.41B | 48.02 | ― | ― | 7.07% | ― | |
70 Neutral | ¥15.30B | 7.47 | ― | 1.48% | 5.86% | -16.20% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
47 Neutral | ¥15.45B | 12.11 | ― | 2.11% | 3.00% | 73.02% | |
46 Neutral | ¥37.39B | 21.75 | ― | 1.65% | -1.17% | -84.81% |